Zhicai Wu – Trademark Portfolio

Entity Type: 01

Zhicai Wu holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 21 (Housewares) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include UALITOR and IPERLIFE. The owner is based in Guangdong Province.

Rm 501,Bldg 3,Linghong Healthy Home,

Nanwan St, Longgang Dist, Shenzhen City,

Guangdong Province 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IPERLIFE
IPERLIFE
Registered 2022
UALITOR
UALITOR
Registered 2020

Trademark Classifications

Zhicai Wu's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does Zhicai Wu have?

Zhicai Wu has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Zhicai Wu file in?

Zhicai Wu files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 21 (Housewares). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Zhicai Wu's most well-known trademarks?

Zhicai Wu's registered trademark portfolio includes well-known marks such as UALITOR and IPERLIFE. These are among 2 currently registered trademarks in the portfolio.

What is Zhicai Wu's trademark registration success rate?

Zhicai Wu has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.